| Q60642962 | A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study |
| Q28680729 | A unified framework for addiction: vulnerabilities in the decision process |
| Q36775263 | Abnormal brain network organization in body dysmorphic disorder |
| Q33785897 | Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. |
| Q35084948 | Advances in the pharmacological treatment of pathological gambling |
| Q35135582 | An overview of Indian research in obsessive compulsive disorder |
| Q42940627 | Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder. |
| Q33794392 | Autism and ADHD symptoms in patients with OCD: are they associated with specific OC symptom dimensions or OC symptom severity? |
| Q37491183 | Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. |
| Q49717601 | Cognitive inflexibility in a young woman with pyromania |
| Q37129770 | Complex obsessive compulsive and impulsive symptoms in Tourette's syndrome. |
| Q35670338 | Compulsive features in behavioural addictions: the case of pathological gambling |
| Q50641588 | Compulsivity and Impulsivity in Pathological Gambling: Does a Dimensional-Transdiagnostic Approach Add Clinical Utility to DSM-5 Classification? |
| Q64230853 | Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation |
| Q35141158 | Construct models in veterinary behavioural medicine: lessons from the human experience. |
| Q92643082 | Demographic and psychiatric correlates of compulsive sexual behaviors in gambling disorder |
| Q37703973 | Dissociative Experiences are Associated with Obsessive-Compulsive Symptoms in a Non-clinical Sample: A Latent Profile Analysis |
| Q36713425 | Fluvoxamine in the treatment of anxiety disorders. |
| Q35690154 | Gambling disorder and other behavioral addictions: recognition and treatment |
| Q34743326 | Gambling: an addictive behavior with health and primary care implications |
| Q37394303 | Impulsivity and response inhibition in alcohol dependence and problem gambling |
| Q36341411 | Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study |
| Q35103456 | Kleptomania in impulse control disorders, obsessive-compulsive disorder, and bipolar spectrum disorder: clinical and therapeutic implications |
| Q34084488 | Kleptomania: diagnosis and treatment options |
| Q26796441 | Misophonia: current perspectives |
| Q21133740 | Misophonia: diagnostic criteria for a new psychiatric disorder |
| Q33961196 | New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity |
| Q35237204 | Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts |
| Q34184771 | Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments |
| Q28293655 | Parkinson's disease-related disorders in the impulsive-compulsive spectrum |
| Q37381883 | Pathological choice: the neuroscience of gambling and gambling addiction |
| Q35237208 | Pathological gambling and compulsive buying: do they fall within an obsessive-compulsive spectrum? |
| Q35574495 | Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder |
| Q37056593 | Pathological gambling: an update on neuropathophysiology and pharmacotherapy |
| Q35961441 | Pediatric obesity: parallels with addiction and treatment recommendations |
| Q24602117 | Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review |
| Q37777328 | Repetitive love proposing: A case report and review of phenomenology of impulsivity and compulsivity |
| Q92171589 | Self-reported and neurocognitive impulsivity in obsessive-compulsive disorder |
| Q48306818 | Suicide risk in somatoform disorders |
| Q33955187 | The neural bases of cognitive processes in gambling disorder |
| Q24642641 | The neurobiology and genetics of impulse control disorders: relationships to drug addictions |
| Q24596812 | The pathophysiology of body dysmorphic disorder |
| Q37472829 | The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions |
| Q35589925 | Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment |
| Q36826802 | Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders |
| Q26860848 | Visual processing in anorexia nervosa and body dysmorphic disorder: similarities, differences, and future research directions |
| Q37384451 | What Causes BDD: Research Findings and a Proposed Model |
| Q36605247 | White matter microstructure in body dysmorphic disorder and its clinical correlates |
| Q51887980 | [Heterogeneity and comorbidity of obsessive-compulsive disorder]. |